Dr. Rick Rhinebarger is a senior executive pharmaceutical manufacturing expert with over 40 years of experience working with biotech and large pharma in lifecycle support, including chemical and formulation process R&D, analytical and process validation, and material characterization. He has been involved in filing over 30 INDs and has worked in the drug chemistry and formulation of 11 approved drugs across multiple disease areas. His expertise is in the application of analytical sciences, with emphasis on chemical process R&D for New Chemical Entities, including applications of separation techniques, as well as spectroscopic and physical methods of analysis to understand chemical processes. For the past 8 years, Dr. Rhinebarger has been an independent consultant advising life sciences companies on CMC matters, Interacting with FDA and audits. Prior to that, he was the Director of the Analytical Division of Cardinal Health, Senior Director of Global Chemical Process R&D at G. D. Searle (Monsanto), Pharmacia and Pfizer.
